Haukeland University Hospital is a hospital in Bergen, Norway, and one of the eleven institutions that make up Bergen Hospital Trust.

There are 1,100 beds in Haukeland Universitetssykehus.

During the past decade, Haukeland Universitetssykehus conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 18 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 15 clinical trials were completed. i.e. 57.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Haukeland Universitetssykehus" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Oslo University Hospital" with 6 trials sponsored, "Haukeland University Hospital" with 5 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored and "Norwegian University of Science and Technology" with 5 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Haukeland Universitetssykehus" #1 collaborator was "Haukeland University Hospital" with 10 trials as a collaborator, "University Hospital of North Norway" with 8 trials as a collaborator, "St. Olavs Hospital" with 7 trials as a collaborator, "Helse Stavanger HF" with 6 trials as a collaborator and "Oslo University Hospital" with 6 trials as a collaborator. Other collaborators include 126 different institutions and companies that were collaborators in the rest 91 trials.

According to Clinical.Site data, the most researched conditions in "Haukeland Universitetssykehus" are "Fabry Disease" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Cancer" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials) and "Leukemia, Myeloid, Acute" (2 trials). Many other conditions were trialed in "Haukeland Universitetssykehus" in a lesser frequency.

Most popular intervention types in "Haukeland Universitetssykehus" are "Drug" (41 trials), "Device" (11 trials), "Other" (6 trials), "Biological" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ocrelizumab" (3 trials), "Atezolizumab" (2 trials), "BI 1015550" (2 trials) and "Bosutinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Haukeland Universitetssykehus" are 75 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Haukeland Universitetssykehus". undefined are not yet recruiting, 19 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 38 completed trials in Haukeland Universitetssykehus, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Haukeland Universitetssykehus, 4 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 13 trials that are defined as “Not Applicable".

Haukeland Universitetssykehus has several departments that took part in Clinical trials: "Department of Oncology, Haukeland University Hospital" - 11 trials, "Department of Heart Disease, Haukeland University Hospital" - 7 trials, "Dep. of Neurology" - 4 trials, "Haukeland University Hospital, Dept of Paediatrics" - 4 trials, "Research Unit for Health Trials" - 2 trials, "Dept. of Occupational Medicine, Haukeland University Hospital" - 2 trials, "Hematologisk seksjon, med avd, Haukeland Universitetssykehus" - 3 trials, "Department of Rheumatology, Haukeland University Hospital, Helse Bergen HF" - 2 trials, "Department of Addiction Medicine, Haukeland University Hospital" - 2 trials, "Department of Medcine, Haukeland University Hospital" - 2 trials, "Kysthospitalet i Hagevik, Orthopeadic Clinic, Haukeland University Hospital" - 2 trials